WallStreetZenWallStreetZen

NASDAQ: XLO
Xilio Therapeutics Inc Stock Ownership - Who owns Xilio Therapeutics?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Xilio Therapeutics Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Gilead Sciences Inc10% Owner2024-04-02485,250$0.76
$368.79kBuy
Atlas Venture Fund Xi LP10% Owner2024-02-08733$0.64
$469.12Sell
Atlas Venture Fund Xi LP10% Owner2024-02-08267$0.64
$170.88Sell
Atlas Venture Fund Xi LP10% Owner2024-01-121,540$0.83
$1.28kSell
Atlas Venture Fund Xi LP10% Owner2024-01-12560$0.83
$464.80Sell
Atlas Venture Fund Xi LP10% Owner2024-01-11569$0.87
$495.03Sell
Atlas Venture Fund Xi LP10% Owner2024-01-111,566$0.87
$1.36kSell

1 of 1

XLO insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when XLO insiders and whales buy or sell their stock.

XLO Shareholders

What type of owners hold Xilio Therapeutics Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Gilead Sciences Inc19.90%6,860,223$8.44MInsider
Sv7 Impact Medicine Fund LP9.36%3,227,264$3.97MInsider
Bain Capital Life Sciences Investors LLC8.14%2,805,413$3.45MInsider
Bain Capital Life Sciences Investors LLC8.14%2,805,413$3.45MInstitution
Atlas Venture Life Science Advisors LLC8.00%2,759,344$3.39MInstitution
Atlas Venture Fund Xi LP7.99%2,754,109$3.39MInsider
James E. Flynn6.64%2,287,944$2.81MInsider
Fmr LLC5.53%1,907,671$2.35MInstitution
Octagon Capital Advisors LP5.18%1,785,000$2.20MInstitution
Takeda Pharmaceutical Co Ltd4.28%1,475,121$1.81MInsider

1 of 3

XLO vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
XLO37.10%62.90%Net BuyingNet Buying
AADI26.99%73.01%Net SellingNet Selling
NXTC47.82%50.20%
BOLT54.74%45.26%Net Selling
CTCX11.98%59.11%Net Buying
View Top Biotech Stocks

Xilio Therapeutics Stock Ownership FAQ

Who owns Xilio Therapeutics?

Xilio Therapeutics (NASDAQ: XLO) is owned by 43.37% institutional shareholders, 73.52% Xilio Therapeutics insiders, and 0.00% retail investors. Gilead Sciences Inc is the largest individual Xilio Therapeutics shareholder, owning 6.86M shares representing 19.90% of the company. Gilead Sciences Inc's Xilio Therapeutics shares are currently valued at $8.78M.

If you're new to stock investing, here's how to buy Xilio Therapeutics stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.